SE9402510L - Förfarande för framställning av substituerade sulfoxider - Google Patents

Förfarande för framställning av substituerade sulfoxider

Info

Publication number
SE9402510L
SE9402510L SE9402510A SE9402510A SE9402510L SE 9402510 L SE9402510 L SE 9402510L SE 9402510 A SE9402510 A SE 9402510A SE 9402510 A SE9402510 A SE 9402510A SE 9402510 L SE9402510 L SE 9402510L
Authority
SE
Sweden
Prior art keywords
pct
date
sec
jul
single enantiomers
Prior art date
Application number
SE9402510A
Other languages
English (en)
Other versions
SE504459C2 (sv
SE9402510D0 (sv
Inventor
Magnus Larsson
Henrik Soerensen
Urban Stenhede
Unge Sverker Von
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20394753&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9402510(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9402510A priority Critical patent/SE504459C2/sv
Publication of SE9402510D0 publication Critical patent/SE9402510D0/sv
Priority to CA002193994A priority patent/CA2193994C/en
Priority to UA97020638A priority patent/UA47409C2/uk
Priority to KR1019970700221A priority patent/KR100356252B1/ko
Priority to SK48-97A priority patent/SK284059B6/sk
Priority to US08/492,087 priority patent/US5948789A/en
Priority to ES95926068T priority patent/ES2199998T5/es
Priority to DK95926068.8T priority patent/DK0773940T4/da
Priority to EP95926068A priority patent/EP0773940B2/en
Priority to AU29948/95A priority patent/AU688074B2/en
Priority to SI9530676T priority patent/SI0773940T2/sl
Priority to DE69530987T priority patent/DE69530987T3/de
Priority to BR9508292A priority patent/BR9508292A/pt
Priority to PCT/SE1995/000818 priority patent/WO1996002535A1/en
Priority to EE9700006A priority patent/EE03354B1/xx
Priority to MX9700358D priority patent/MX9700358A/es
Priority to AT95926068T priority patent/ATE242233T1/de
Priority to RU97102162/04A priority patent/RU2157806C2/ru
Priority to JP50493896A priority patent/JP3795917B2/ja
Priority to PT95926068T priority patent/PT773940E/pt
Priority to TW084106875A priority patent/TW372971B/zh
Priority to PL95318165A priority patent/PL186342B1/pl
Priority to NZ289959A priority patent/NZ289959A/en
Priority to HU9700108A priority patent/HU226361B1/hu
Priority to CZ0006497A priority patent/CZ297987B6/cs
Priority to CN95194956A priority patent/CN1070489C/zh
Priority to IL11447795A priority patent/IL114477A/en
Priority to ZA955724A priority patent/ZA955724B/xx
Priority to MA23950A priority patent/MA23611A1/fr
Priority to EG57195A priority patent/EG24534A/xx
Priority to DZ950088A priority patent/DZ1911A1/fr
Priority to HR950401A priority patent/HRP950401B1/xx
Priority to TNTNSN95081A priority patent/TNSN95081A1/fr
Priority to YU47695A priority patent/YU49475B/sh
Priority to MYPI95001998A priority patent/MY113180A/en
Priority to TR95/00861A priority patent/TR199500861A2/xx
Priority to SA95160294A priority patent/SA95160294B1/ar
Publication of SE9402510L publication Critical patent/SE9402510L/sv
Priority to ARP960103398A priority patent/AR003443A1/es
Priority to IS4406A priority patent/IS1772B/is
Priority to FI970102D priority patent/FI117830B/sv
Priority to FI970102A priority patent/FI117672B/sv
Priority to NO19970153A priority patent/NO312101B1/no
Publication of SE504459C2 publication Critical patent/SE504459C2/sv
Priority to HK98109230A priority patent/HK1008331A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE9402510A 1994-07-15 1994-07-15 Förfarande för framställning av substituerade sulfoxider SE504459C2 (sv)

Priority Applications (43)

Application Number Priority Date Filing Date Title
SE9402510A SE504459C2 (sv) 1994-07-15 1994-07-15 Förfarande för framställning av substituerade sulfoxider
JP50493896A JP3795917B2 (ja) 1994-07-15 1995-07-03 置換スルホキシドの合成法
PT95926068T PT773940E (pt) 1994-07-15 1995-07-03 Processo de sintese de sulfoxidos substituidos
AU29948/95A AU688074B2 (en) 1994-07-15 1995-07-03 Process for synthesis of substituted sulphoxides
SI9530676T SI0773940T2 (sl) 1994-07-15 1995-07-03 Postopek za sintezo substituiranih sulfoksidov
KR1019970700221A KR100356252B1 (ko) 1994-07-15 1995-07-03 치환술폭시드의합성방법
SK48-97A SK284059B6 (sk) 1994-07-15 1995-07-03 Spôsob prípravy substituovaných sulfoxidov
US08/492,087 US5948789A (en) 1994-07-15 1995-07-03 Process for synthesis of substituted sulphoxides
ES95926068T ES2199998T5 (es) 1994-07-15 1995-07-03 Procedimiento para la síntesis de sulfóxidos sustituidos.
DK95926068.8T DK0773940T4 (da) 1994-07-15 1995-07-03 Fremgangsmåde til syntese af substituerede sulfoxider
EP95926068A EP0773940B2 (en) 1994-07-15 1995-07-03 Process for synthesis of substituted sulphoxides
CA002193994A CA2193994C (en) 1994-07-15 1995-07-03 Process for synthesis of substituted sulphoxides
UA97020638A UA47409C2 (uk) 1994-07-15 1995-07-03 Спосіб синтезу заміщених сульфоксидів (варіанти) та сульфоксид
DE69530987T DE69530987T3 (de) 1994-07-15 1995-07-03 Verfahren zur herstellung von substituierten sulfoxiden
BR9508292A BR9508292A (pt) 1994-07-15 1995-07-03 Processos para a sintese enãncio-seletiva de um composto,(-)-5-metóxi-2[[(4-metóxi-3,5-dimetil-2-piridinil) metil]sulfinil]-1h-benzimidazol,(+)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-carbometóxi-6-metil-2-[[(3,4-dimetóxi-2-piridinil) metil] sulfinil]-1h-benzimidazol,(+)-5-carbometóxi-6-metil-2-[[(3,4-dimetóxi-2-piridinil) metil] sulfinil]-1h benzimidazol composto e uso dos compostos
PCT/SE1995/000818 WO1996002535A1 (en) 1994-07-15 1995-07-03 Process for synthesis of substituted sulphoxides
EE9700006A EE03354B1 (et) 1994-07-15 1995-07-03 Asendatud sulfoksiidide sünteesi protsess
MX9700358D MX9700358A (es) 1994-07-15 1995-07-03 Proceso par a la sintesis de sulfoxidos substituidos.
AT95926068T ATE242233T1 (de) 1994-07-15 1995-07-03 Verfahren zur herstellung von substituierten sulfoxiden
RU97102162/04A RU2157806C2 (ru) 1994-07-15 1995-07-03 Способы синтеза замещенных сульфоксидов
TW084106875A TW372971B (en) 1994-07-15 1995-07-04 Process for synthesis of substituted sulphoxides
CZ0006497A CZ297987B6 (cs) 1994-07-15 1995-07-05 Zpusob prípravy substituovaných sulfoxidu
NZ289959A NZ289959A (en) 1994-07-15 1995-07-05 Process for enantioselective synthesis of substituted 2-[(2-pyridinyl(or phenyl)methyl)sulphinyl]-1h-[benzimidazole (or thienoimidazole)] (including omeprazole) and other structurally related suphoxides and salts thereof
PL95318165A PL186342B1 (pl) 1994-07-15 1995-07-05 Sposób enancjoselektywnej syntezy związku sulfotlenkowego
CN95194956A CN1070489C (zh) 1994-07-15 1995-07-05 取代的亚砜类化合物的合成方法
HU9700108A HU226361B1 (en) 1994-07-15 1995-07-05 Process for synthesis of substituted sulphoxides
IL11447795A IL114477A (en) 1994-07-15 1995-07-06 A process for the enantioselective synthesis of converted sulfoxides, individual enantiomers obtained as a result of the process and their use in the preparation of drugs
ZA955724A ZA955724B (en) 1994-07-15 1995-07-10 Process for synthesis of substituted sulphoxides
MA23950A MA23611A1 (fr) 1994-07-15 1995-07-10 Procede pour la synthese de sulfoxydes substitues
EG57195A EG24534A (en) 1994-07-15 1995-07-11 Process for synthesis of substituted sulfoxides
DZ950088A DZ1911A1 (fr) 1994-07-15 1995-07-11 Procédé pour la synthèse de sulfoxydes substitues.
HR950401A HRP950401B1 (en) 1994-07-15 1995-07-12 Process for synthesis of substituted sulphoxides
TNTNSN95081A TNSN95081A1 (fr) 1994-07-15 1995-07-13 Procede pour la synthese de sulfoxydes substitues
TR95/00861A TR199500861A2 (tr) 1994-07-15 1995-07-14 Ikame edilmis sulfoksidlerin sentezi icin proses.
YU47695A YU49475B (sh) 1994-07-15 1995-07-14 Postupak za sintezu supstituisanih sulfoksida
MYPI95001998A MY113180A (en) 1994-07-15 1995-07-14 Process for synthesis of substituted sulfoxides
SA95160294A SA95160294B1 (ar) 1994-07-15 1995-10-07 عملية لتحضير synthesisمركبات سلفوكسيد مستبدلة substituted sulphoxide
ARP960103398A AR003443A1 (es) 1994-07-15 1996-06-28 Procedimiento para la purificacion optica de preparaciones enantiomericamente enriquecidas de compuestos derivados de 2-sulfinil-bencimidazol
IS4406A IS1772B (is) 1994-07-15 1996-12-27 Aðferð við myndun útskiptra súlfoxíða
FI970102D FI117830B (sv) 1994-07-15 1997-01-10 Förfarande för syntetisering av substituerade sulfoxider
FI970102A FI117672B (sv) 1994-07-15 1997-01-10 Förfarande för syntetisering av substituerade sulfoxider
NO19970153A NO312101B1 (no) 1994-07-15 1997-01-14 Fremgangsmåte for syntese av substituerte sulfoksider, og slike produktforbindelser
HK98109230A HK1008331A1 (en) 1994-07-15 1998-07-17 Process for synthesis of substituted sulphoxides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402510A SE504459C2 (sv) 1994-07-15 1994-07-15 Förfarande för framställning av substituerade sulfoxider

Publications (3)

Publication Number Publication Date
SE9402510D0 SE9402510D0 (sv) 1994-07-15
SE9402510L true SE9402510L (sv) 1996-01-16
SE504459C2 SE504459C2 (sv) 1997-02-17

Family

ID=20394753

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402510A SE504459C2 (sv) 1994-07-15 1994-07-15 Förfarande för framställning av substituerade sulfoxider

Country Status (42)

Country Link
US (1) US5948789A (sv)
EP (1) EP0773940B2 (sv)
JP (1) JP3795917B2 (sv)
KR (1) KR100356252B1 (sv)
CN (1) CN1070489C (sv)
AR (1) AR003443A1 (sv)
AT (1) ATE242233T1 (sv)
AU (1) AU688074B2 (sv)
BR (1) BR9508292A (sv)
CA (1) CA2193994C (sv)
CZ (1) CZ297987B6 (sv)
DE (1) DE69530987T3 (sv)
DK (1) DK0773940T4 (sv)
DZ (1) DZ1911A1 (sv)
EE (1) EE03354B1 (sv)
EG (1) EG24534A (sv)
ES (1) ES2199998T5 (sv)
FI (2) FI117672B (sv)
HK (1) HK1008331A1 (sv)
HR (1) HRP950401B1 (sv)
HU (1) HU226361B1 (sv)
IL (1) IL114477A (sv)
IS (1) IS1772B (sv)
MA (1) MA23611A1 (sv)
MX (1) MX9700358A (sv)
MY (1) MY113180A (sv)
NO (1) NO312101B1 (sv)
NZ (1) NZ289959A (sv)
PL (1) PL186342B1 (sv)
PT (1) PT773940E (sv)
RU (1) RU2157806C2 (sv)
SA (1) SA95160294B1 (sv)
SE (1) SE504459C2 (sv)
SI (1) SI0773940T2 (sv)
SK (1) SK284059B6 (sv)
TN (1) TNSN95081A1 (sv)
TR (1) TR199500861A2 (sv)
TW (1) TW372971B (sv)
UA (1) UA47409C2 (sv)
WO (1) WO1996002535A1 (sv)
YU (1) YU49475B (sv)
ZA (1) ZA955724B (sv)

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
US6747155B2 (en) 1997-05-30 2004-06-08 Astrazeneca Ab Process
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
EP0994877A1 (en) 1997-07-03 2000-04-26 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704183D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New process
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP2002501897A (ja) * 1998-01-30 2002-01-22 セプラコール， インク． Ｒ−ランソプラゾール組成物及び方法
AU3870599A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. R-rabeprazole compositions and methods
AU3967399A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. S-rabeprazole compositions and methods
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
CN1087739C (zh) * 1998-12-28 2002-07-17 中国科学院成都有机化学研究所 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
ATE298334T1 (de) 1999-06-30 2005-07-15 Takeda Pharmaceutical Kristalle von lansoprazole
AU6727700A (en) * 1999-08-25 2001-03-19 Takeda Chemical Industries Ltd. Process for the preparation of optically active sulfoxide derivatives
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6982275B2 (en) 2000-04-28 2006-01-03 Takeda Pharmaceutical Company Limited Process for producing optically active sulfoxide derivative
KR100869677B1 (ko) 2000-05-15 2008-11-21 다케다 야쿠힌 고교 가부시키가이샤 결정의 제조방법
CA2409044C (en) * 2000-05-15 2013-02-19 Takeda Chemical Industries, Ltd. Improved recrystallization processes for obtaining anhydrous optically active lansoprazole
JP5412023B2 (ja) 2000-08-04 2014-02-12 武田薬品工業株式会社 ベンズイミダゾール化合物の塩およびその用途
CA2436825C (en) 2000-12-01 2011-01-18 Takeda Chemical Industries, Ltd. Process for the crystallization of (r)- or (s)-lansoprazole
AU2002338655A1 (en) * 2001-04-13 2002-10-28 Aspinterm Llc Methods of preparing sulfinamide and sulfoxides
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
EP1487818B1 (en) * 2002-03-05 2007-05-30 AstraZeneca AB Alkylammonium salts of omeprazole and esomeprazole
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US7169793B2 (en) 2002-06-27 2007-01-30 Dr. Reddy's Laboratories Limited Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004035052A1 (ja) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤
WO2004037253A1 (en) 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
DK1575941T3 (da) * 2002-12-06 2012-07-09 Nycomed Gmbh Fremgangsmåde til fremstilling af (S)-pantoprazol
PT1578742E (pt) * 2002-12-06 2013-01-24 Nycomed Gmbh Processo para preparar compostos activos opticamente puros
WO2004055001A2 (en) * 2002-12-16 2004-07-01 Ranbaxy Laboratories Limited Rabeprazole calcium
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CA2510849A1 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
WO2004060263A2 (en) * 2003-01-07 2004-07-22 Ranbaxy Laboratories Limited Magnesium salt of imidazole derivative
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
CA2517714A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphs of s-omeprazole
US20040235904A1 (en) * 2003-03-12 2004-11-25 Nina Finkelstein Crystalline and amorphous solids of pantoprazole and processes for their preparation
EP1611901B1 (en) * 2003-03-13 2013-07-10 Eisai R&D Management Co., Ltd. Preventive or remedy for teeth grinding
CA2520157A1 (fr) * 2003-03-28 2004-10-14 Sidem Pharma Procede de preparation enantioselective de derives de sulfoxydes
FR2852956B1 (fr) * 2003-03-28 2006-08-04 Negma Gild Procede de preparation enantioselective de derives de sulfoxydes
US20070060556A1 (en) * 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
MXPA05013316A (es) 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
WO2005054228A1 (en) * 2003-12-05 2005-06-16 Hetero Drugs Limited A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US7176319B2 (en) * 2004-04-28 2007-02-13 Hetero Drugs Limited Process for substituted sulfoxides
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
PT1748998E (pt) * 2004-05-28 2010-03-24 Hetero Drugs Ltd Novo processo de síntese estereoselectiva de sulfóxidos de benzimidazol
EP1758889A1 (en) * 2004-06-02 2007-03-07 Altana Pharma AG Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
MXPA06015031A (es) * 2004-06-24 2007-02-08 Astrazeneca Ab Nuevo proceso para la preparacion de modificaciones cristalinas para usarse en la preparacion de sal de sodio de esomeprazol.
US20080249134A1 (en) * 2004-06-24 2008-10-09 Ursula Hohlneicher New Esomeprazole Sodium Salt Crystal Modification
FR2876101B1 (fr) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
SI1802584T1 (sl) * 2004-10-11 2010-01-29 Ranbaxy Lab Ltd Postopki za pripravo substituiranih sulfoksidov
US7592111B2 (en) * 2004-11-05 2009-09-22 Xerox Corporation Imaging member
CN101098867B (zh) * 2005-03-25 2010-08-11 丽珠医药集团股份有限公司 取代的亚砜类化合物和其制备方法及用途
WO2006099810A1 (en) 2005-03-25 2006-09-28 Livzon Pharmaceutical Group Inc. Substituted sulfoxide compounds, methods for preparing the same and use thereof
RU2007145207A (ru) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
US8247566B2 (en) * 2005-06-08 2012-08-21 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
BRPI0619158A2 (pt) * 2005-12-05 2011-09-20 Astrazeneca Ab processo para preparar forma que não que não seja sal de esomeprazol, composto, formulação farmacêutica, e, método de tratamento
DE102005061720B3 (de) * 2005-12-22 2006-10-19 Ratiopharm Gmbh Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
SI1973896T1 (sl) 2005-12-28 2009-08-31 Union Quimico Farma Postopek priprave (S) - enantiomere omeprazola
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
US8063074B2 (en) * 2006-05-04 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of esomeprazole sodium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
BRPI0621832A2 (pt) 2006-07-05 2013-03-19 Lupin Ltd processo para a preparaÇço de enantiâmeros oticamente puros ou oticamente enriquecidos de compostos de sulfàxido
WO2008018091A1 (en) * 2006-08-08 2008-02-14 Jubilant Organosys Limited Process for producing sulphoxide compounds
JP2009196894A (ja) * 2006-10-13 2009-09-03 Eisai R & D Management Co Ltd スルフィニルベンズイミダゾール化合物またはその塩の製造方法
WO2008047681A1 (fr) 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
CA2889878A1 (en) 2007-02-21 2008-08-28 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
WO2008149204A1 (en) * 2007-06-07 2008-12-11 Aurobindo Pharma Limited An improved process for preparing an optically active proton pump inhibitor
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
EP2203441A4 (en) * 2007-10-03 2012-02-15 Ipca Lab Ltd PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS
EP2195309A4 (en) 2007-10-08 2013-04-24 Hetero Drugs Ltd SALT POLYMORPHS OF THE ESOMEPRAZOLE
MY153062A (en) 2007-10-12 2014-12-31 Takeda Pharmaceuticals Usa Inc Methods of treating gastrointestinal disorders independent of the intake of food
FR2925899B1 (fr) * 2007-12-27 2012-12-21 Sidem Pharma Sa Procede de preparation enantioselective de sulfoxydes.
CN101492459B (zh) * 2008-01-25 2011-04-27 山东轩竹医药科技有限公司 含烷氧乙酰基二氢异噁唑并吡啶化合物
CN101497603B (zh) * 2008-01-30 2012-11-07 山东轩竹医药科技有限公司 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
PE20091680A1 (es) 2008-03-10 2009-11-16 Takeda Pharmaceutical Cristal de compuestos de bencimidazol
EP2265605A4 (en) * 2008-03-18 2011-08-03 Reddys Lab Ltd Dr METHOD OF MANUFACTURING DEXLANSOPRAZOLE AND POLYMORPHIDE THEREOF
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
WO2009145368A1 (en) * 2008-05-27 2009-12-03 Sk Chemicals Co., Ltd. Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
US20100113527A1 (en) * 2008-09-30 2010-05-06 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
IT1391776B1 (it) 2008-11-18 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo
CZ200990A3 (cs) * 2009-02-16 2010-08-25 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
CZ2009172A3 (cs) * 2009-03-17 2010-09-29 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
US20130030186A1 (en) * 2009-06-02 2013-01-31 Sun Pharmaceutical Industries Limited Process for preparing sulphoxide compounds
IT1395118B1 (it) 2009-07-29 2012-09-05 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo cristallino
WO2011058569A1 (en) 2009-11-12 2011-05-19 Hetero Research Foundation Process for the resolution of omeprazole
US20130197232A1 (en) 2010-01-29 2013-08-01 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
US8912337B2 (en) 2010-06-24 2014-12-16 Cipla Limited Salts and polymorphs of dexrabeprazole
CN101914090B (zh) * 2010-08-13 2013-03-20 埃斯特维华义制药有限公司 左旋奥美拉唑的制备方法
CN102558150B (zh) * 2010-12-31 2014-03-12 正大天晴药业集团股份有限公司 取代亚砜化合物的合成方法
CN102321071B (zh) * 2011-07-20 2013-01-23 江苏奥赛康药业股份有限公司 一种高纯度埃索美拉唑钠的工业化生产方法
CN102977076A (zh) * 2011-09-02 2013-03-20 扬子江药业集团上海海尼药业有限公司 一种右兰索拉唑的制备方法
CN102329302A (zh) * 2011-10-22 2012-01-25 刘强 一种埃索美拉唑及其盐的制备方法
CN102408412A (zh) * 2011-10-25 2012-04-11 广东华南药业集团有限公司 高对映体选择性制备（s）- 奥美拉唑的方法
CN102432412A (zh) * 2011-10-28 2012-05-02 成都欣捷高新技术开发有限公司 一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法
KR101300950B1 (ko) * 2011-10-31 2013-08-27 르노삼성자동차 주식회사 전기자동차의 공기 흡입 장치
WO2013140120A1 (en) 2012-03-22 2013-09-26 Cipla Limited Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
CN102633776B (zh) * 2012-03-28 2014-06-18 中山市仁合药业有限公司 一种埃索美拉唑及其钠盐的制备方法
CN102659763B (zh) * 2012-04-27 2014-01-22 南京优科生物医药研究有限公司 一种右旋兰索拉唑合成与纯化的方法
CN103044402B (zh) * 2012-12-31 2015-01-14 康普药业股份有限公司 埃索美拉唑钠合成生产方法
CN103113351B (zh) * 2013-03-08 2015-01-21 苏州特瑞药业有限公司 一种光学纯手性亚砜类化合物的制备方法
CN104177336A (zh) * 2013-05-28 2014-12-03 上海汇伦生命科技有限公司 一种对映选择性合成右兰索拉唑的方法
EP2929885A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
WO2015155281A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and proton pump inhibitors
EP2980086B1 (en) 2014-07-29 2016-06-15 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Efficient process for the preparation of esomeprazole (S)-binol complex
CN107428726B (zh) * 2014-12-26 2021-03-16 国立大学法人东京大学 光学活性的质子泵抑制剂化合物的制备方法
CN104610226A (zh) * 2014-12-31 2015-05-13 广东东阳光药业有限公司 一种右兰索拉唑的不对称氧化方法
EP3064495B1 (en) 2015-03-06 2016-12-14 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of optically pure esomeprazole
CN105218392B (zh) * 2015-07-09 2017-11-21 天津青松华药医药有限公司 D‑酒石酸单酯单酰胺类化合物
CN105218391B (zh) * 2015-07-09 2017-11-21 天津青松华药医药有限公司 L‑酒石酸单酯单酰胺类化合物
CN105968097B (zh) * 2016-05-17 2019-05-03 杭州华东医药集团新药研究院有限公司 左旋泮托拉唑的工业化生产方法
CN106083818A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种高纯度埃索美拉唑钠的制备方法
CN106366070B (zh) * 2016-08-10 2019-06-11 上海万巷制药有限公司 一种高纯度埃索美拉唑钠的制备方法
CN106632249A (zh) * 2016-09-30 2017-05-10 青岛云天生物技术有限公司 一种制备(s)‑泮托拉唑钠的方法
CN106632248A (zh) * 2016-09-30 2017-05-10 青岛云天生物技术有限公司 一种左旋泮托拉唑钠的制备工艺
CN106866630B (zh) * 2017-04-01 2018-08-07 上海华源医药科技发展有限公司 一种右兰索拉唑的制备方法
CN110746428A (zh) * 2019-10-29 2020-02-04 株洲千金药业股份有限公司 一种r型手性亚砜类化合物的制备方法
CN110698482A (zh) * 2019-10-29 2020-01-17 株洲千金药业股份有限公司 一种s型手性亚砜类化合物的制备方法
CN113845510A (zh) * 2020-06-27 2021-12-28 鲁南制药集团股份有限公司 一种埃索美拉唑的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation

Also Published As

Publication number Publication date
ATE242233T1 (de) 2003-06-15
KR970704731A (ko) 1997-09-06
ES2199998T3 (es) 2004-03-01
MY113180A (en) 2001-12-31
SK4897A3 (en) 1997-08-06
AU688074B2 (en) 1998-03-05
HK1008331A1 (en) 1999-05-07
SK284059B6 (sk) 2004-09-08
CN1157614A (zh) 1997-08-20
EP0773940B1 (en) 2003-06-04
FI117672B (sv) 2007-01-15
CA2193994C (en) 2005-05-03
NO970153L (no) 1997-01-14
YU49475B (sh) 2006-05-25
IS1772B (is) 2001-06-01
NO970153D0 (no) 1997-01-14
HRP950401B1 (en) 2004-04-30
DZ1911A1 (fr) 2002-02-17
WO1996002535A1 (en) 1996-02-01
SE504459C2 (sv) 1997-02-17
CA2193994A1 (en) 1996-02-01
AR003443A1 (es) 1998-08-05
JPH10504290A (ja) 1998-04-28
DK0773940T3 (da) 2003-09-15
KR100356252B1 (ko) 2002-11-18
UA47409C2 (uk) 2002-07-15
FI970102A0 (sv) 1997-01-10
ES2199998T5 (es) 2011-03-16
EE03354B1 (et) 2001-02-15
BR9508292A (pt) 1997-12-23
NO312101B1 (no) 2002-03-18
JP3795917B2 (ja) 2006-07-12
IL114477A0 (en) 1995-11-27
RU2157806C2 (ru) 2000-10-20
DE69530987T2 (de) 2004-05-19
ZA955724B (en) 1996-01-15
EP0773940B2 (en) 2010-11-17
FI117830B (sv) 2007-03-15
DE69530987D1 (de) 2003-07-10
SI0773940T1 (en) 2004-02-29
PL318165A1 (en) 1997-05-26
EG24534A (en) 2009-08-30
YU47695A (sh) 1998-07-10
CZ297987B6 (cs) 2007-05-16
WO1996002535A8 (en) 1999-12-23
MA23611A1 (fr) 1996-04-01
HUT76642A (en) 1997-10-28
MX9700358A (es) 1997-04-30
AU2994895A (en) 1996-02-16
DE69530987T3 (de) 2011-07-07
EP0773940A1 (en) 1997-05-21
SA95160294B1 (ar) 2006-07-31
SI0773940T2 (sl) 2011-02-28
TR199500861A2 (tr) 1996-06-21
CN1070489C (zh) 2001-09-05
HU226361B1 (en) 2008-09-29
CZ6497A3 (en) 1997-06-11
FI970102A (sv) 1997-01-10
IL114477A (en) 2001-07-24
TW372971B (en) 1999-11-01
PT773940E (pt) 2003-10-31
US5948789A (en) 1999-09-07
HRP950401A2 (en) 1997-10-31
SE9402510D0 (sv) 1994-07-15
IS4406A (is) 1996-12-27
DK0773940T4 (da) 2011-02-07
NZ289959A (en) 1998-01-26
TNSN95081A1 (fr) 1996-02-06
PL186342B1 (pl) 2003-12-31

Similar Documents

Publication Publication Date Title
SE9402510L (sv) Förfarande för framställning av substituerade sulfoxider
ATE232907T1 (de) Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidation
FR2692264B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
NO972912D0 (no) Fremstilling av tabletter som kan deles
FI20030932A (sv) Förfarande för upplösning av cis-enatiomerer av FTC
DE69525840T2 (de) Herstellung von arthropodiziden oxadiazinen
ATE40884T1 (de) Zwischenverbindungen fuer die herstellung von omeprazol.
FI792149A (fi) (d1)-16-fenoxi- och 16-substituerad-fenoxi-9-keto-prostatriensyraderivat och foerfarande foer deras framstaellning
FI952677A0 (sv) Förfarande för framställning av väsentligen rena enantiomerer av fenylpropionsyra
DE69525950D1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
HU9802206D0 (en) Intravenous thaidomid composition for treating immunological diseases
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
DE69604054D1 (de) Herstellung von mit enantiomer angereicherten ortho-substituierten alpha, alpha-diaromatischen methanolen
NZ332545A (sv)
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
KR890006621A (ko) 항불안제
ATE84074T1 (de) Verfahren zur fermentativen herstellung von 2-(4- hydroxiphenoxi-)propionsaeure.
ATE216702T1 (de) Silylierungsprocess
ATE399876T1 (de) Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate
ATE78060T1 (de) Stereospezifische ketoreduktion von bicyclooctandion-carbonsaeureestern durch mikroorganismen.
ATE202332T1 (de) Herstellung und verwendung der reinen enantiomere der 8-halogen-6-hydroxyoctansäuren, ihrer alkylester und ihrer salze mit reinen enantiomeren des alpha-methylbenzylamins
ATE295728T1 (de) Herstellung von 3-fluoroxindolderivaten
TH23382A (th) กรรมวิธีสำหรับสังเคราะห์ซับสทิทิวเทดซัลฟอกไซด์
NO972291L (no) Fremgangsmåte for fremstilling av optisk aktive forbindelser
DE19681129D2 (de) Verwendung des alpha,alpha-Diphenylessigsäure-4-(N-Methyl-Piperidyl)esters als Spasmoanalgetikum

Legal Events

Date Code Title Description
NUG Patent has lapsed